News search

E.g., 12/04/2025
E.g., 12/04/2025
Susana Carmona durante su conferencia
Research
5 Dec 2024

Susana Carmona directs the Neuromaternal research group at the Gregorio Marañón Hospital in Madrid

El Dr. Valentín Fuster recibe el Premio de la Sociedad Internacional de Aterosclerosis
About the CNIC
5 Dec 2024

The International Atherosclerosis Society recognizes the contributions to the understanding and treatment of atherosclerosis by the director of the National Center for Cardiovascular Research (CNIC) and president of the Mount Sinai Fuster Heart

Carola Vinuesa
About the CNIC
25 Nov 2024

Carola García de Vinuesa is a senior group leader at the Francis Crick Institute in London and the John Curtin School of Medical Research in Canberra.

imagen
About the CNIC
23 Oct 2024

The National Center for Cardiovascular Research (CNIC), and the Health Research Institute of Hospital 12 de Octubre (i+12), representing SERMAS, are actively participating in JACARDI through different pilot projects

imagen
About the CNIC
2 Oct 2024
Cardiovascular risk factors (particularly metabolic syndrome, insulin resistance, and diabetes) alter coronary microvascular function and increase the risk of atherosclerotic disease, which itself leads to changes in the coronary microcirculation.
Research
19 Sep 2024

A study from CNIC reveals how risk factors and subclinical atherosclerosis affect heart microcirculation in asymptomatic middle-aged individuals. The research, published in JACC: Cardiovascular Imaging, highlights the importance of assessing the heart vessels' ability to regulate blood flow and predict future cardiovascular risk

image
Research
9 Sep 2024

The new study, published in the journal Circulation, opens a new avenue of research into treatments for the atherosclerosis associated with progeria

team photo
About the CNIC
11 Jun 2024

iSuRe-HadCre promises to become an essential tool for biomedical research using mouse models to modify and understand gene function

 Dr. Fuster
About the CNIC
15 May 2024

Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and encourage prevention. Denmark’s Novo Nordisk Foundation has granted up to EUR 23 million to cover the first 2.5 years of the REACT initiative. The initiative is expected to run for 8 years in total